International Consortium of Orthopaedic Registers (ICOR)
ICOR was established by the U.S. Food and Drug Administration (FDA) and rolled out during a workshop in May 2011. The intent of this workshop was to facilitate discussion among FDA and worldwide orthopaedic registries that have implant information to further collaborate through a research network that pools the collective experience and available data. Dr. David G. Lewallen serves as a member of the ICOR Steering Committee. Initial ICOR projects currently underway include development of a worldwide implant database, comparison of various bearings used in hip arthroplasty, and comparison of fixed and mobile bearings used in knee arthroplasty. Learn more about ICOR here.